BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12755666)

  • 1. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
    Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
    J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
    Sernyak MJ; Gulanski B; Rosenheck R
    J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
    Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
    J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
    Miller MJ; Molla PM
    Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus associated with clozapine therapy.
    Wehring H; Alexander B; Perry PJ
    Pharmacotherapy; 2000 Jul; 20(7):844-7. PubMed ID: 10907975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine and associated diabetes mellitus.
    Popli AP; Konicki PE; Jurjus GJ; Fuller MA; Jaskiw GE
    J Clin Psychiatry; 1997 Mar; 58(3):108-11. PubMed ID: 9108812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.
    Cohen D; Stolk RP; Grobbee DE; Gispen-de Wied CC
    Diabetes Care; 2006 Apr; 29(4):786-91. PubMed ID: 16567816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine.
    Wu G; Dias P; Chun W; Li G; Kumar S; Singh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1395-400. PubMed ID: 11125862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.
    Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S
    Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study.
    Schmidt MI; Duncan BB; Vigo A; Pankow J; Ballantyne CM; Couper D; Brancati F; Folsom AR;
    Diabetes Care; 2003 May; 26(5):1338-43. PubMed ID: 12716785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.